Your browser doesn't support javascript.
loading
Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire.
Millar, Douglas G; Yang, S Y Cindy; Sayad, Azin; Zhao, Qingchuan; Nguyen, Linh T; Warner, Kathrin; Sangster, Ami G; Nakatsugawa, Munehide; Murata, Kenji; Wang, Ben X; Shaw, Patricia; Clarke, Blaise; Bernardini, Marcus Q; Pugh, Trevor; Thibault, Pierre; Hirano, Naoto; Perreault, Claude; Ohashi, Pamela S.
Afiliación
  • Millar DG; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Yang SYC; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Sayad A; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Zhao Q; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
  • Nguyen LT; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Warner K; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Sangster AG; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Nakatsugawa M; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Murata K; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Wang BX; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Shaw P; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Clarke B; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Bernardini MQ; Division of Gynecologic Oncology, Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Pugh T; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Thibault P; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
  • Hirano N; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.
  • Perreault C; Department of Immunology, University of Toronto, Toronto, ON, Canada.
  • Ohashi PS; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
Cancer Immunol Immunother ; 72(7): 2375-2392, 2023 Jul.
Article en En | MEDLINE | ID: mdl-36943460
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Linfocitos Infiltrantes de Tumor Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Male Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Linfocitos Infiltrantes de Tumor Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Male Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Canadá